Athenex Inc (ATNX)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track Share on 𝕏

Stock chart

Ticker: ATNX Exchange: NSM

Subscribe to get access to the transaction volume chart and in-chart transaction details

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale

Past 90 days

Value bought

Value sold

Net insiders buying

Trades (buy and sell)

Company data

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Total value
2018-05-24	2018-05-21	S Sale	Trainor-Degirolamo Sheldon Non-Executive Director	23,920 -2.8% 17.01 406,879 USD	23,920 -2.8%	17.01	406,879 USD
2018-05-24	2018-05-18	S Sale	Trainor-Degirolamo Sheldon Non-Executive Director	38,729 -4.3% 17.01 658,780 USD	38,729 -4.3%	17.01	658,780 USD
2018-05-24	2018-05-17	S Sale	Trainor-Degirolamo Sheldon Non-Executive Director	989 -0.1% 17.01 16,823 USD	989 -0.1%	17.01	16,823 USD
2018-05-23	2018-05-17	S Sale	Zhang Song-Yi Non-Executive Director Major owner	26,250 -0.4% 16.87 442,838 USD	26,250 -0.4%	16.87	442,838 USD
2018-05-23	2018-05-16	S Sale	Zhang Song-Yi Non-Executive Director Major owner	44,506 -0.8% 16.84 749,481 USD	44,506 -0.8%	16.84	749,481 USD
2018-05-24	2018-05-15	S Sale	Trainor-Degirolamo Sheldon Non-Executive Director	38,047 -4.0% 17.00 646,799 USD	38,047 -4.0%	17.00	646,799 USD
2018-05-23	2018-05-15	S Sale	Zhang Song-Yi Non-Executive Director Major owner	29,244 -0.5% 16.93 495,101 USD	29,244 -0.5%	16.93	495,101 USD
2018-03-26	2018-03-26	B Purchase	Kwan Rudolf EVP, Chief Medical Officer	2,000 +2.5% 14.65 29,300 USD	2,000 +2.5%	14.65	29,300 USD
2018-03-26	2018-03-26	B Purchase	YORDON JEFFREY See Remarks	5,000 +2.7% 14.69 73,450 USD	5,000 +2.7%	14.69	73,450 USD
2018-03-26	2018-03-26	B Purchase	LAU JOHNSON YIU NAM CEO and Chairman of the Board Executive Director	12,500 +0.5% 14.76 184,500 USD	12,500 +0.5%	14.76	184,500 USD
2018-03-26	2018-03-26	B Purchase	WU JINN	10,000 +4.0% 14.66 146,600 USD	10,000 +4.0%	14.66	146,600 USD
2018-02-09	2018-02-09	B Purchase	WU JINN Non-Executive Director	10,000 +4.2% 13.64 136,432 USD	10,000 +4.2%	13.64	136,432 USD
2018-02-09	2018-02-08	B Purchase	LAU JOHNSON YIU NAM CEO and Chairman of the Board Executive Director	20,000 +0.7% 14.40 287,906 USD	20,000 +0.7%	14.40	287,906 USD
2018-02-09	2018-02-08	B Purchase	Fok Manson Non-Executive Director	20,000 +1.1% 14.44 288,872 USD	20,000 +1.1%	14.44	288,872 USD
2018-02-09	2018-02-07	B Purchase	Fok Manson Non-Executive Director	30,000 +1.7% 14.31 429,315 USD	30,000 +1.7%	14.31	429,315 USD
2017-06-21	2017-06-19	B Purchase	LAU JOHNSON YIU NAM CEO and Chairman of the Board	25,200 +0.9% 11.00 277,200 USD	25,200 +0.9%	11.00	277,200 USD
2017-06-21	2017-06-19	B Purchase	Fok Manson	300,000 +20.4% 11.00 3,300,000 USD	300,000 +20.4%	11.00	3,300,000 USD
2017-06-21	2017-06-19	B Purchase	Zhang Song-Yi	181,818 +inf% 11.00 1,999,998 USD	181,818 +inf%	11.00	1,999,998 USD
2017-06-21	2017-06-19	B Purchase	Zhang Song-Yi	146,819 +2.2% 11.00 1,615,009 USD	146,819 +2.2%	11.00	1,615,009 USD
2017-06-21	2017-06-19	B Purchase	Leung Antony	300,000 0.00 0 USD	300,000	0.00	0 USD